Chargement en cours...
ISS-Ⅲ期伴1q扩增或17p缺失双重打击初诊多发性骨髓瘤患者的预后分析
OBJECTIVE: To evaluate the prognostic significance of combining ISS-Ⅲ and high risk cytogenetic abnormalities [HRCAs, including 1q gain/amplification and del (17p) ] in patients with newly-diagnosed multiple myeloma (NDMM) . METHODS: The clinical characteristics and relevant variables were retrospec...
Enregistré dans:
| Publié dans: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Editorial office of Chinese Journal of Hematology
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342365/ https://ncbi.nlm.nih.gov/pubmed/31856439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.11.005 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|